Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 167 | 7,562−4%/yr | −4%/yr | 3.31.0× | 15% | 8,490 in 2030+1.9%/yr |
| Lumbar fusion | 165 | 7,337+0.8%/yr | +0.8%/yr | 3.21.0× | 7% | 9,130 in 2030+3.7%/yr |
| Kyphoplasty & vertebroplasty | 71 | 5,916−5%/yr | −5%/yr | 2.61.7× | 52% | 6,240 in 2030+0.9%/yr |
| Cervical fusion & disc arthroplasty | 85 | 3,684−1%/yr | −1%/yr | 1.60.9× | 7% | 4,300 in 2030+2.6%/yr |
| SI joint fusion | 18 | 1,158+12%/yr | +12%/yr | 0.51.6× | 66% | 2,840 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 1,336 | 505,568+2.5%/yr | +2.5%/yr | 215.02.3× | 54% | 587,700 in 2030+2.5%/yr |
| Skin substitutes & wound grafts | 307 | 65,607+28%/yr | +28%/yr | 16.81.8× | 81% | 135,200 in 2030+13%/yr |
| Bone graft & orthobiologics | 34 | 1,353−8.3%/yr | −8.3%/yr | 0.60.8× | 6% | 1,490 in 2030+1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 451 | 40,806+0.5%/yr | +0.5%/yr | 17.41.3× | 95% | 48,900 in 2030+3.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 65 | 3,941+8.8%/yr | +8.8%/yr | 1.61.2× | 74% | 5,860 in 2030+6.8%/yr |
| Spinal cord & DRG stimulation | 48 | 1,901−2%/yr | −2%/yr | 0.80.8× | 65% | 2,240 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 243 | 23,074−4.3%/yr | −4.3%/yr | 9.81.9× | 100% | 26,100 in 2030+2.1%/yr |
| Peripheral arterial intervention | 132 | 20,074−3.1%/yr | −3.1%/yr | 8.51.5× | 70% | 23,800 in 2030+2.9%/yr |
| Dialysis access | 93 | 10,783−15%/yr | −15%/yr | 5.00.9× | 68% | 10,100 in 2030−1%/yr |
| Thrombectomy, IVC filters & venous stents | 55 | 5,650+1.5%/yr | +1.5%/yr | 2.61.7× | 32% | 8,010 in 2030+6%/yr |
| Carotid revascularization | 67 | 3,226−2.7%/yr | −2.7%/yr | 1.41.1× | 0% | 3,330 in 2030+0.5%/yr |
| Aortic endografts (EVAR/TEVAR) | 10 | 1,226−4.3%/yr | −4.3%/yr | 0.61.2× | 0% | 1,210 in 2030−0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 187 | 13,939−2.8%/yr | −2.8%/yr | 6.71.1× | 7% | 15,700 in 2030+2%/yr |
| Cholecystectomy & appendectomy | 212 | 9,319−5.5%/yr | −5.5%/yr | 4.30.9× | 1% | 10,300 in 2030+1.7%/yr |
| Colorectal resection | 14 | 3,627−6.3%/yr | −6.3%/yr | 1.71.0× | 0% | 3,630 in 20300%/yr |
| Antireflux & hiatal hernia surgery | 30 | 1,735−2.6%/yr | −2.6%/yr | 0.81.0× | 0% | 2,220 in 2030+4.2%/yr |
| Breast reconstruction | 11 | 1,327−4.8%/yr | −4.8%/yr | 0.61.3× | 4% | 1,340 in 2030+0.2%/yr |
| Bariatric surgery | 1 | 424−17%/yr | −17%/yr | 0.21.0× | 0% | 320 in 2030−4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 187 | 13,311−3.9%/yr | −3.9%/yr | 5.91.3× | 45% | 13,300 in 20300%/yr |
| Kidney stone management | 245 | 10,751−1.7%/yr | −1.7%/yr | 4.90.9× | 18% | 11,800 in 2030+1.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 107 | 6,731+0.7%/yr | +0.7%/yr | 3.01.2× | 30% | 7,480 in 2030+1.8%/yr |
| Hysterectomy, hysteroscopy & ablation | 83 | 6,350−1.1%/yr | −1.1%/yr | 3.11.2× | 27% | 7,730 in 2030+3.3%/yr |
| Prostatectomy & nephrectomy | 36 | 2,467−0.1%/yr | −0.1%/yr | 1.21.0× | 0% | 2,810 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 144 | 14,5270%/yr | 0%/yr | 6.61.4× | 92% | 19,700 in 2030+5.2%/yr |
| Ear tubes & middle ear surgery | 6 | 650−5.8%/yr | −5.8%/yr | 0.30.9× | 70% | 680 in 2030+0.7%/yr |
| Sleep apnea & airway implants | 17 | 501+55%/yr | +55%/yr | 0.20.9× | 6% | 600 in 2030+3.1%/yr |
| Cochlear implants | 9 | 349+4.4%/yr | +4.4%/yr | 0.20.9× | 30% | 300 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 245 | 16,085−0.7%/yr | −0.7%/yr | 7.71.2× | 39% | 18,600 in 2030+2.5%/yr |
| Tumor & fibroid embolization | 29 | 1,301+2.9%/yr | +2.9%/yr | 0.61.0× | 55% | 3,590 in 2030+18%/yr |
| Tumor ablation | 3 | 795+1.4%/yr | +1.4%/yr | 0.41.2× | 0% | 1,250 in 2030+7.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 404 | 65,371+15%/yr | +15%/yr | 28.71.0× | 96% | 130,100 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| LAA occlusion & loop recorders | 310 | 13,955+10%/yr | +10%/yr | 5.31.7× | 38% | 26,400 in 2030+11%/yr |
| Pacemaker, ICD & CRT implantation | 252 | 13,475−2.8%/yr | −2.8%/yr | 6.31.2× | 8% | 13,600 in 2030+0.2%/yr |
| EP ablation | 189 | 11,766+7.3%/yr | +7.3%/yr | 4.31.2× | 0% | 19,400 in 2030+8.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 398 | 18,276−5%/yr | −5%/yr | 6.51.1× | 5% | 19,500 in 2030+1.1%/yr |
| Structural heart (TAVR, TEER) | 217 | 4,689+3.4%/yr | +3.4%/yr | 1.71.2× | 0% | 6,380 in 2030+5.3%/yr |
| Mechanical circulatory support | 5 | 1,323−3.5%/yr | −3.5%/yr | 0.61.1× | 0% | 1,380 in 2030+0.8%/yr |
| PFO & septal closure | 0 | 224+0.5%/yr | +0.5%/yr | 0.11.3× | 0% | 310 in 2030+5.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 40 | 1,299+18%/yr | +18%/yr | 0.61.4× | 0% | 2,280 in 2030+9.8%/yr |
| Stroke thrombectomy | 32 | 1,063+2.8%/yr | +2.8%/yr | 0.51.2× | 0% | 1,080 in 2030+0.2%/yr |
| DBS & VNS | 13 | 844+0.5%/yr | +0.5%/yr | 0.41.2× | 2% | 1,550 in 2030+11%/yr |
| CSF shunts | 5 | 505−6.4%/yr | −6.4%/yr | 0.21.3× | 0% | 470 in 2030−1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 588 | 114,602−2.3%/yr | −2.3%/yr | 50.40.8× | 95% | 126,900 in 2030+1.7%/yr |
| Vitreoretinal surgery | 76 | 6,413−2.9%/yr | −2.9%/yr | 2.91.2× | 87% | 6,520 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 1,186 | 280,238−2.5%/yr | −2.5%/yr | 131.01.2× | 59% | 307,900 in 2030+1.6%/yr |
| ERCP & endoscopic ultrasound | 119 | 8,114−0.6%/yr | −0.6%/yr | 3.71.2× | 6% | 9,910 in 2030+3.4%/yr |
| Bronchoscopy & lung nodule | 120 | 7,940+6.4%/yr | +6.4%/yr | 3.61.1× | 0% | 13,100 in 2030+8.7%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.